trial · primary record
Duvelisib
Chronic Lymphocytic Leukemia
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 55 |
| Primary completion | 2026-07-01 |
| Primary endpoint | Complete Response Rate (CRR) |
| Registry ID | NCT03534323 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:53.986Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03534323
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.